MCIM
WVE icon

Meadow Creek Investment Management’s Wave Life Sciences WVE Stock Holding History

Meadow Creek Investment Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-990
Closed -$26K – 1388
2019
Q2 		$26K Buy
990
+198
+25% +$5.55K ﹤0.01% 1316
2019
Q1 		$31K Buy
792
+198
+33% +$8.03K ﹤0.01% 1293
2018
Q4 		$25K Buy
+594
New +$26.4K ﹤0.01% 1249
2018
Q3 		– Sell
-462
Closed -$18K – 1337
2018
Q2 		$18K Buy
+462
New +$19.9K ﹤0.01% 1293

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Meadow Creek Investment Management's WVE Position: Q3 2019 in Review

Meadow Creek Investment Management sold out of Wave Life Sciences (WVE) in Q3 2019, closing a stake of 990 shares — an estimated $26K sold.

Meadow Creek Investment Management first reported a position in WVE in Q2 2018 and held it in 4 quarters. The position peaked at $31K in Q1 2019. 88 funds tracked by Wall St. Rank hold WVE as of Q3 2019.

  • Meadow Creek Investment Management reported no remaining Wave Life Sciences position as of Q3 2019 after selling out during the quarter.
  • Meadow Creek Investment Management sold 990 Wave Life Sciences shares in Q3 2019, an estimated $26K.
  • Meadow Creek Investment Management first reported a position in Wave Life Sciences in Q2 2018 and held it in 4 quarters.
  • Meadow Creek Investment Management's Wave Life Sciences position peaked at $31K in Q1 2019.
  • 88 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2019.

Based on Meadow Creek Investment Management's 13F filing for Q3 2019, filed 14 Nov 2019.